V
VIR
Vir Biotechnology, Inc.
9.52
+0.35+3.82%After Hours: 9.54 +0.02 +0.21%19:01 04/08 EDT
OPEN/PREV CLOSE9.47/9.17
TODAY RANGE9.20-9.71
VOL2.51M
MARKET CAP1.50B
52 WEEK RANGE4.155-10.94
AVG VOL (3M)3.57M
% TURNOVER1.60%
TURNOVER--
P/E (TTM)-3.0108
% RANGE5.51%
EPS(TTM)-3.1619
P/E(FORWARD)-7.1579
P/B1.735
BVPS5.49
DIVIDEND--
P/S19.37
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.20B
SHARES OUTSTANDING157.16M
NEXT EARNINGS05/05-05/11
FREE FLOAT126.52M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·4d ago
Is Vir Biotechnology’s (VIR) Insider Selling After Its Capital Raise Reframing the Investment Narrative?
Simply Wall St·03/08 15:13
Why Vir Biotechnology (VIR) Is Up 5.1% After Astellas Cancer Deal And Equity Raise News
TipRanks·03/04 22:00
Vir Biotechnology Names CEO Marianne De Backer as President
Reuters·03/04 21:03
Vir Biotech Names CEO Marianne De Backer President
Benzinga·03/04 12:35
Semtech To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Simply Wall St·03/04 12:29
Assessing Vir Biotechnology (VIR) Valuation After Astellas Alliance And VIR-5500 Phase 1 Update
Dow Jones·03/04 12:11
Vir Biotechnology Is Maintained at Buy by HC Wainwright & Co.
TipRanks·03/04 11:16
Vir Biotechnology price target raised to $20 from $15 at H.C. Wainwright
Reuters·03/04 09:14
U.S. RESEARCH ROUNDUP-CrowdStrike, Oracle, Vulcan Materials
Same Industry
Name/Symbol
Change%
Price